Please use the dropdown box to search by Health Topic or use the tabs above to browse by date, guest or sponsor.
Download MP3 |
Download Transcript
|
One medical question that has confused postmenopausal women for years is should a woman take hormone replacement therapy, specifically the combined used of estrogen plus progestin? Does it increase the risk of breast cancer? Are there health benefits, like building bone and fighting osteoporosis? A new study published in the New England Journal of Medicine supports the hypothesis that the recent reduction in U.S. breast cancer incidence is predominately related to the decrease in the use of these combined hormones, estrogen plus progestin.
When this news came to the forefront, Patient Power invited Dr. Ross Prentice, Senior Vice-President and Director of Public Health Sciences at the Fred Hutchinson Cancer Research Center, to help listeners understand this study and what it means for women. Dr. Prentice, who was a contributor to the study published in the New England Journal of Medicine, begins by explaining the study, why it was conducted and what the results show. He shares information about low-dose hormone replacement therapy and how it impacts these recent findings.
Dr. Peter McGough, Chief Medical Officer of the UW Medicine Neighborhood Clinics, a part of UW Medicine, also joins Andrew to offer his insight. Dr. McGough lends his opinion on the topic and also speaks about alternative ways to protect the bones and heart. If you have questions about this topic or are looking for a medical explanation about the findings of this study, this Patient Power program is a valuable resource.
Guests:
Ross Prentice, PhD, MSc, Director of Public Health Sciences Division, Fred Hutchinson Cancer Research Center
Peter McGough, M.D., Chief Medical Officer, UW Medicine Neighborhood Clinics
